SCHEMBL629237

SCHEMBL629237

CON=C(C)c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 20/20 0.70
KDR P35968 15/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL629236 1.00 FGFR3 (0.70) FGFR3KDR
SCHEMBL557555 0.91 FGFR3 (0.67) FGFR3KDR
SCHEMBL557556 0.91 FGFR3 (0.67) FGFR3KDR
SCHEMBL556272 0.91 FGFR3 (0.73) FGFR3KDR
SCHEMBL556273 0.91 FGFR3 (0.73) FGFR3KDR
SCHEMBL557207 0.90 FGFR3 (0.66) FGFR3KDR
SCHEMBL10265482 0.90 FGFR3 (0.66) FGFR3KDR
SCHEMBL556723 0.90 FGFR3 (0.68) FGFR3KDR
SCHEMBL556722 0.90 FGFR3 (0.68) FGFR3KDR
SCHEMBL557526 0.90 FGFR3 (0.85) FGFR3KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2419427-A1 BICYCLIC HETEROCYCLYL DERIVATIVES AS FGFR KINASE INHIBITORS FOR THERAPEUTIC USE Astex Therapeutics Ltd. (GB) 2012-02-22 EP disclosed
WO-2010119284-A1 BICYCLIC HETEROCYCLYL DERIVATIVES AS FGFR KINASE INHIBITORS FOR THERAPEUTIC USE ASTEX THERAPEUTICS LIMITED (GB) 2010-10-21 WO disclosed